Financial Services Agency

Securities / Derivatives

Japan FSA Sends Bill to Parliament to Boost Capital Market

By Editors | 19/03/2024

The bill will enable asset managers to outsource middle and back office operations and facilitate the development of a market for unlisted securities.

Japan to Offer Investment Visas to Venture Capitalists – Report

By Editors | 18/03/2024

A new five-year residency visa will reportedly be available to angel investors and venture capitalists in the next few months.

Market Infrastructure

Japan to Permanently Cease Euroyen TIBOR on 30 December

By Editors | 07/03/2024

ISDA confirmed that the announcement from JBA TIBOR Administration “constitutes an index cessation event”.

Big Picture

Japan’s Market and Corporate Reforms – New Dawn or Déjà Vu?

By Gavin Blair | 05/03/2024

Reforms to boost the capital market and asset management sector are driving optimism in Japan.

ESG / Sustainability

Japan to Require Emissions Disclosures from Top-tier Firms

By Editors | 05/03/2024

The FSA is expected to release draft standards by end-March proposing requirements for Prime Market companies to disclose supply chain emissions data.

Enforcement

Japan: Major Insurers Commit to Divesting Cross-Held Shares

By Editors | 03/03/2024

The insurers also imposed disciplinary measures against 132 executives and employees, including pay cuts, over a price-fixing scandal.

Enforcement

SG Firm Allegedly Swindled JPY 135 Billion in Japan’s Largest Scam

By Nithya Subramanian | 01/03/2024

Sky Premium International has been accused of involvement in foreign exchange margin trading, labeled as an illegitimate “pyramid scheme”, wooing investors through a network of 570 salespeople.

Crypto / Digital Assets

HK-based Crypto Firm BitForex Disappears With User Funds

By Mark Johnston | 27/02/2024

$56mn in crypto was removed from the exchange before it stopped processing transactions and responding to user queries.

Capital / Liquidity

CFTC Grants TAIFEX Exemption to Clear Swaps for US Participants

By Manesh Samtani | 26/02/2024

TAIFEX has relied on temporary no-action relief since September 2022. ‘Exempt DCO’ status gives it a lasting right to clear OTC derivatives for US participants.